GC Biopharma Corp. (KRX:006280)
South Korea · Delayed Price · Currency is KRW 130,800
+1,700 (1.32%)
Oct 28, 2026, 2:50 PM KST
GC Biopharma Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, GC Biopharma stock has a consensus rating of "Buy" and an average price target of ₩191,000. The average 1-year stock price forecast is 46.02% higher than the current stock price, while the lowest is ₩165,000 (+26.15%) and the highest is ₩220,000 (+68.20%).
Price Target: ₩191,000 (+46.02%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for GC Biopharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 3 | 3 | 3 |
| Buy | 6 | 6 | 6 | 5 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 8 | 8 | 8 |
Financial Forecast
Revenue This Year
1.94T
from 1.99T
Decreased by -2.36%
Revenue Next Year
2.07T
from 1.94T
Increased by 6.52%
EPS This Year
21.36K
from -410.00
EPS Next Year
4.62K
from 21.36K
Decreased by -78.36%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.